Researchers have developed CMGL, a novel two-stage framework for cancer subtype classification that integrates multi-omics data. This method addresses challenges posed by varying data quality and noise across different patient samples and cancer types. CMGL estimates sample-specific modality reliability using evidential deep learning, which then guides the fusion of omics data and the construction of patient similarity graphs, leading to improved classification accuracy. AI
Summary written by gemini-2.5-flash-lite from 2 sources. How we write summaries →
IMPACT Introduces a new method for improving cancer subtype classification by leveraging multi-omics data and evidential deep learning.
RANK_REASON This is a research paper detailing a new method for cancer subtype classification using multi-omics data.